EUVIMEDEUVIMED entdecken
Crossref

The Transmuting Tier-Transitional Cell Carcinoma

Journal of Surgery and Surgical Procedures · 2022

DOI: 10.47485/3069-8154.1001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Surgery and Surgical Procedures, 2022. Die Arbeit nennt 4 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transitional cell carcinoma emerges from malignant transmutation of transitional epithelium layering intrinsic surface of urinary bladder, ureter, urethra and urachus. Classically, carcinoma of urinary bladder exhibits painless, episodic, intermittent, gross or microscopic haematuria. Transitional cell carcinoma predominantly expounds papillary lesions (70%) whereas nearly 30% neoplasms are non papillary. Transitional cell carcinoma enunciates somatic mutations with genomic deletions in chromosome 9q,9p,11p,17p,13q,14q along with overexpression of RAS oncogene and epidermal growth factor receptor (EGFR). Localized transitional cell carcinoma is aptly subjected to surgical resection.

Zitieren

APA

(2022). The Transmuting Tier-Transitional Cell Carcinoma. Journal of Surgery and Surgical Procedures. https://doi.org/10.47485/3069-8154.1001

Vancouver

The Transmuting Tier-Transitional Cell Carcinoma. Journal of Surgery and Surgical Procedures. 2022. doi:10.47485/3069-8154.1001

BibTeX
@article{euvimed2022,
  title = {The Transmuting Tier-Transitional Cell Carcinoma},
  journal = {Journal of Surgery and Surgical Procedures},
  year = {2022},
  doi = {10.47485/3069-8154.1001}
}
Kostenlos starten →